Clinical Trial Update: Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients. [NA]

View source ↗

Summary

This clinical trial investigates the effects of SGLT2 inhibitors in patients on chronic peritoneal dialysis due to end-stage renal disease. The study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• SGLT2 inhibitors (class)

Snippet

Sponsor: Oman Ministry of Health | Conditions: End Stage Chronic Renal Failure | NA | Status: RECRUITING